Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Therapeutic Solutions International, Inc. TSOI OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
24/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Therapeutic Solutions International, Inc. (TSOI) is a Biotechnology company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 23/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $98,994, +40.8%/yr average growth. Net income is $2M (loss), growing at -0.6%/yr. Net profit margin is -2191.9% (negative). Gross margin is 62.9% (-16.7 pp trend).

Balance sheet: total debt is $888,064 against $1M equity (Debt-to-Equity (D/E) ratio 0.79, moderate). Current ratio is 0.05 (tight liquidity). Debt-to-assets is 27%. Total assets: $3M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 17/100 (Fail), Moat 35/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

TSOI SharesGrow Score Overview

30/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 17/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 35/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — TSOI

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
TSOI: +40.8%/yr revenue is, -0.6%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
17/100
Balance sheet TSOI: Debt-to-Equity (D/E) ratio 0.79 (moderate), Current ratio is 0.05 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
35/100
TSOI: Gross margin is 62.9% (-16.7 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 35/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
TSOI: Net profit margin is -2191.9%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.0001-0.0003
Volume262.5K
Avg Volume (30D)4.42M
Market Cap$512.27K
Beta (1Y)0.45
Share Statistics
EPS (TTM)0.00
Shares Outstanding$3.17B
IPO Date2008-06-24
Employees3
CEOTimothy George Dixon
Financial Highlights & Ratios
Revenue (TTM)$98.99K
Gross Profit$62.23K
EBITDA$-1.49M
Net Income$-2.17M
Operating Income$-1.99M
Total Cash$27.82K
Total Debt$888.06K
Net Debt$860.24K
Total Assets$3.29M
Price / Earnings (P/E)-0.1
Price / Sales (P/S)5.17
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS8833781011

Price Chart

Track all markets on TradingView
TSOI
Therapeutic Solutions International, Inc. ↗  ·  Other OTC
Healthcare • Biotechnology
0.00 52WK RANGE 0.00

People Also View

ZURA
ZURA
Zura Bio Limited
$5.72
+0.70%
 YS
YS
YS Biopharma Co., Ltd.
$1.02
+9.68%
 ACOGF
ACOGF
Alpha Cognition Inc.
$5.73
+0.00%
 TXTM
TXTM
ProText Mobility, Inc.
$0.01
-2.41%
 APM
APM
Aptorum Group Limited
$0.88
+0.69%
 ENSC
ENSC
Ensysce Biosciences, Inc.
$0.52
-5.66%
 HILS
HILS
Hillstream BioPharma, Inc.
$0.24
+5.66%
 PHGE
PHGE
BiomX Inc.
$2.21
-15.97%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message